421.04
price up icon0.59%   2.46
after-market Handel nachbörslich: 421.00 -0.04 -0.01%
loading
Schlusskurs vom Vortag:
$418.58
Offen:
$420.63
24-Stunden-Volumen:
429.82K
Relative Volume:
0.56
Marktkapitalisierung:
$18.99B
Einnahmen:
$3.08B
Nettoeinkommen (Verlust:
$1.24B
KGV:
16.44
EPS:
25.6108
Netto-Cashflow:
$1.07B
1W Leistung:
-2.69%
1M Leistung:
-2.69%
6M Leistung:
+44.50%
1J Leistung:
+20.76%
1-Tages-Spanne:
Value
$411.92
$422.39
1-Wochen-Bereich:
Value
$411.92
$432.20
52-Wochen-Spanne:
Value
$266.98
$459.48

United Therapeutics Corp Stock (UTHR) Company Profile

Name
Firmenname
United Therapeutics Corp
Name
Telefon
(301) 608-9292
Name
Adresse
1000 SPRING ST, SILVER SPRING, MD
Name
Mitarbeiter
1,305
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-30
Name
Neueste SEC-Einreichungen
Name
UTHR's Discussions on Twitter

Vergleichen Sie UTHR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
421.04 18.93B 3.08B 1.24B 1.07B 25.61
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
147.53 64.68B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.17 44.25B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.20 41.19B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
19.61 21.74B 16.70B -157.13M 1.19B -0.1446

United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-20 Eingeleitet Wells Fargo Underweight
2025-09-26 Eingeleitet RBC Capital Mkts Outperform
2025-06-02 Eingeleitet Cantor Fitzgerald Overweight
2025-04-25 Herabstufung Wells Fargo Overweight → Equal Weight
2025-04-21 Hochstufung BofA Securities Underperform → Neutral
2024-07-11 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-02-12 Hochstufung Goldman Sell → Neutral
2024-02-05 Eingeleitet Leerink Partners Outperform
2023-12-08 Eingeleitet Wells Fargo Overweight
2022-12-06 Eingeleitet UBS Buy
2022-12-05 Eingeleitet Goldman Sell
2022-10-11 Eingeleitet Morgan Stanley Overweight
2022-09-20 Bestätigt BofA Securities Underperform
2022-09-19 Fortgesetzt Wedbush Outperform
2022-02-11 Eingeleitet BTIG Research Neutral
2021-07-14 Hochstufung Argus Hold → Buy
2021-04-26 Fortgesetzt Credit Suisse Outperform
2021-02-01 Hochstufung H.C. Wainwright Neutral → Buy
2020-09-14 Fortgesetzt JP Morgan Overweight
2020-06-25 Bestätigt H.C. Wainwright Neutral
2020-03-10 Hochstufung Jefferies Hold → Buy
2020-02-27 Hochstufung Cowen Market Perform → Outperform
2020-01-31 Hochstufung JP Morgan Neutral → Overweight
2019-12-03 Eingeleitet BofA/Merrill Underperform
2019-08-01 Hochstufung Jefferies Underperform → Hold
2019-08-01 Hochstufung Ladenburg Thalmann Neutral → Buy
2019-07-01 Hochstufung Credit Suisse Neutral → Outperform
2019-05-17 Hochstufung UBS Sell → Neutral
2019-05-09 Hochstufung Credit Suisse Underperform → Neutral
2018-10-12 Hochstufung Standpoint Research Hold → Buy
2018-08-08 Herabstufung Credit Suisse Neutral → Underperform
2018-04-03 Hochstufung Credit Suisse Underperform → Neutral
2018-02-22 Bestätigt Barclays Underweight
2018-01-18 Fortgesetzt Credit Suisse Underperform
2017-12-27 Bestätigt Wedbush Outperform
2017-04-27 Bestätigt Wedbush Outperform
2017-03-30 Eingeleitet UBS Sell
2017-03-16 Eingeleitet Credit Suisse Underperform
Alle ansehen

United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten

pulisher
05:22 AM

United Therapeutics’ Xenokidney Study: A New Hope for ESRD Patients - TipRanks

05:22 AM
pulisher
04:27 AM

United Therapeutics’ DeciPHer-ILD Study: A Closer Look at PH-ILD Patient Registry - TipRanks

04:27 AM
pulisher
02:55 AM

United Therapeutics’ PHINDER Study: A Step Forward in Early Detection of Pulmonary Hypertension - TipRanks

02:55 AM
pulisher
01:55 AM

United Therapeutics Advances Ralinepag Study for PAH Treatment - TipRanks

01:55 AM
pulisher
04:31 AM

Will United Therapeutics Corporation stock benefit from upcoming earnings reports2025 Risk Factors & Reliable Breakout Forecasts - newser.com

04:31 AM
pulisher
04:00 AM

What margin trends mean for United Therapeutics Corporation stockMarket Growth Review & Consistent Profit Trading Strategies - newser.com

04:00 AM
pulisher
Oct 26, 2025

Nepsis Liquidates $14 Million CyberArk Software (NASDAQ: CYBR) Position: Did the Stock Soar Too High, Too Fast? - The Motley Fool

Oct 26, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 13:21:57 - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Will United Therapeutics Corporation benefit from macro trendsMarket Weekly Review & Precise Swing Trade Alerts - newser.com

Oct 26, 2025
pulisher
Oct 25, 2025

How United Therapeutics Corporation (UTH) stock benefits from digital adoptionJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com

Oct 25, 2025
pulisher
Oct 22, 2025

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView

Oct 22, 2025
pulisher
Oct 22, 2025

United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Oct 22, 2025
pulisher
Oct 21, 2025

What data driven models say about United Therapeutics Corporation’s future2025 Sector Review & Fast Moving Stock Watchlists - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Risk adjusted return profile for United Therapeutics Corporation analyzedJuly 2025 Volume & Fast Gain Swing Trade Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

What makes United Therapeutics Corporation stock attractive to growth fundsTrade Risk Assessment & Precise Trade Entry Recommendations - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

United Therapeutics Executives Sell Shares - TradingView

Oct 20, 2025
pulisher
Oct 20, 2025

United Therapeutics EVP & General Counsel Sells 11,000 Shares - TradingView

Oct 20, 2025
pulisher
Oct 20, 2025

Why United Therapeutics Corporation (UTH) stock gets analyst attention2025 Buyback Activity & Reliable Momentum Entry Alerts - newser.com

Oct 20, 2025
pulisher
Oct 18, 2025

United Therapeutics Corporation (UTHR) Stock forecasts - Yahoo

Oct 18, 2025
pulisher
Oct 18, 2025

Will United Therapeutics Corporation (UTH) stock attract long term capital inflowsJuly 2025 Setups & Weekly High Potential Alerts - Trung tâm Dự báo KTTV quốc gia

Oct 18, 2025
pulisher
Oct 16, 2025

Jefferies Reiterates Buy Rating on United Therapeutics (UTHR) Amid Patent Case - Insider Monkey

Oct 16, 2025
pulisher
Oct 15, 2025

United Therapeutics CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView

Oct 15, 2025
pulisher
Oct 13, 2025

PH-ILD hospitalization data on inhaled treprostinil — United Therapeutics at CHEST 2025 - Stock Titan

Oct 13, 2025
pulisher
Oct 13, 2025

Callan Family Office LLC Increases Stock Position in United Therapeutics Corporation $UTHR - MarketBeat

Oct 13, 2025
pulisher
Oct 12, 2025

United Therapeutics (FRA:UTH) Gross-Profit-to-Asset % : 35.18% (As of Jun. 2025) - GuruFocus

Oct 12, 2025
pulisher
Oct 12, 2025

UTHR (United Therapeutics) Cyclically Adjusted PB Ratio : 4.79 (As of Oct. 12, 2025) - GuruFocus

Oct 12, 2025
pulisher
Oct 12, 2025

Inspire Investing LLC Trims Stock Position in United Therapeutics Corporation $UTHR - MarketBeat

Oct 12, 2025
pulisher
Oct 12, 2025

UTHR (United Therapeutics) 5-Year RORE % : 17.31% (As of Jun. 2025) - GuruFocus

Oct 12, 2025
pulisher
Oct 12, 2025

UTHR (United Therapeutics) Revenue per Share : $63.53 (TTM As of Jun. 2025) - GuruFocus

Oct 12, 2025
pulisher
Oct 09, 2025

Martine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

United Therapeutics Corp. Hits New 52-Week High of $455.26 - Markets Mojo

Oct 09, 2025
pulisher
Oct 09, 2025

United Therapeutics Corp. Hits New 52-Week High of $459.48 - Markets Mojo

Oct 09, 2025
pulisher
Oct 08, 2025

United Therapeutics Corp. Hits New 52-Week High of $455.00 - Markets Mojo

Oct 08, 2025
pulisher
Oct 08, 2025

United Therapeutics (NASDAQ:UTHR) Sets New 52-Week HighHere's What Happened - MarketBeat

Oct 08, 2025
pulisher
Oct 07, 2025

Insider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 22,500 Shares of Stock - MarketBeat

Oct 07, 2025
pulisher
Oct 06, 2025

QRG Capital Management Inc. Raises Stock Position in United Therapeutics Corporation $UTHR - MarketBeat

Oct 06, 2025
pulisher
Oct 05, 2025

Is There Still an Opportunity in United Therapeutics After Its 25.8% Year to Date Surge? - simplywall.st

Oct 05, 2025
pulisher
Oct 04, 2025

Polaris Capital Management LLC Reduces Stock Position in United Therapeutics Corporation $UTHR - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

Hilltop National Bank Takes $341,000 Position in United Therapeutics Corporation $UTHR - MarketBeat

Oct 04, 2025
pulisher
Oct 04, 2025

What Catalysts Are Reshaping the Narrative for United Therapeutics This Year? - Yahoo Finance

Oct 04, 2025
pulisher
Oct 03, 2025

A Look at United Therapeutics (UTHR) Valuation as Tyvaso Shows Breakthrough Results in Late-Stage IPF Trial - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

How Positive TETON-2 Results for Tyvaso Have Changed United Therapeutics' (UTHR) Investment Story - simplywall.st

Oct 03, 2025
pulisher
Oct 03, 2025

News impact scoring models applied to United Therapeutics CorporationPortfolio Growth Summary & Weekly Top Gainers Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Robeco Institutional Asset Management B.V. Boosts Stake in United Therapeutics Corporation $UTHR - MarketBeat

Oct 03, 2025
pulisher
Oct 02, 2025

United Therapeutics stock hits all-time high at 442.02 USD - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

United Therapeutics stock hits all-time high at 442.02 USD By Investing.com - Investing.com South Africa

Oct 02, 2025
pulisher
Oct 02, 2025

United Therapeutics rides Tyvaso optimism as IPF trial gains momentum - S&P Global

Oct 02, 2025
pulisher
Oct 02, 2025

TD Cowen maintains Buy rating on United Therapeutics stock, citing IPF opportunity - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

Jefferies reiterates Buy rating on United Therapeutics stock amid patent case - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

UBS maintains United Therapeutics stock Buy rating amid patent litigation By Investing.com - Investing.com Canada

Oct 02, 2025
pulisher
Oct 01, 2025

United Therapeutics COO sells $9.49m in UTHR stock By Investing.com - Investing.com South Africa

Oct 01, 2025

Finanzdaten der United Therapeutics Corp-Aktie (UTHR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$19.61
price up icon 3.48%
$148.94
price up icon 3.43%
$10.42
price up icon 0.68%
drug_manufacturers_specialty_generic RDY
$14.47
price down icon 0.75%
$22.27
price up icon 1.00%
Kapitalisierung:     |  Volumen (24h):